Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine. Academic Article uri icon

Overview

publication date

  • May 20, 1997

Research

keywords

  • Adenoviridae
  • Antimetabolites
  • Flucytosine
  • Genetic Therapy
  • Genetic Vectors
  • Liver Neoplasms
  • Prodrugs

Identity

Scopus Document Identifier

  • 16944365155

PubMed ID

  • 9195221

Additional Document Info

volume

  • 8

issue

  • 8